Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau… - The lancet …, 2017 - thelancet.com
Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …
被引用次数：508 相关文章

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau, S Lentzsch… - The Lancet …, 2017 - infona.pl
The International Myeloma Working Group consensus aimed to provide recommendations
for the optimal use of 18fluorodeoxyglucose (18F-FDG) PET/CT in patients with multiple …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau… - THE LANCET …, 2017 - cris.unibo.it
Abstract The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18fluorodeoxyglucose (18F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni… - The Lancet …, 2017 - researchinformation.amsterdamumc …
Abstract The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18fluorodeoxyglucose (18F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau, S Lentzsch… - The Lancet …, 2017 - Elsevier
Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni… - The Lancet …, 2017 - portal.findresearcher.sdu.dk
Abstract The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau… - The Lancet …, 2017 - europepmc.org
The International Myeloma Working Group consensus aimed to provide recommendations
for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in patients with multiple …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni… - The Lancet …, 2017 - mayoclinic.elsevierpure.com
Abstract The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni… - The lancet …, 2017 - mdanderson.elsevierpure.com
Abstract The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau… - The Lancet …, 2017 - pubmed.ncbi.nlm.nih.gov
The International Myeloma Working Group consensus aimed to provide recommendations
for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in patients with multiple …